Sat.Jul 22, 2023 - Fri.Jul 28, 2023

article thumbnail

Are practice-based pharmacists entitled to a pay rise?

The Pharmacist

With many staff across primary care entitled to a pay uplift, The Pharmacist takes a look at how recent pay deals will impact pharmacists working in general practice and Primary Care Networks (PCNs). 6% uplift for salaried practice staff – at employer discretion This month, the Department of Health and Social Care (DHSC) announced a […] The post Are practice-based pharmacists entitled to a pay rise?

94
article thumbnail

His book on the opioid crisis flopped in 2003. It now has a new life on Netflix

STAT

A new Netflix TV show about the origins and consequences of the opioid epidemic is coming to the small screen. The show, “Painkiller,” is a fictional story based on real events that transpired around the Sackler family, Purdue Pharma, and the marketing and distribution of their drug, OxyContin. It adds to the growing list of television shows and movies around America’s opioid crisis, including Netflix’s own “The Pharmacist,” Hulu’s “Dopesic

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Trick of Trade: Alternative to a Pressure Bag for IV Fluids

ALiEM - Pharm Pearls

You have a severely dehydrated patient with a peripheral IV line, requiring urgent fluid resuscitation. However, the crystalloid fluids are not flowing freely. Multiple attempts were made to place this line with the latest having a flash of blood return and a smoothly flowing saline flush. You can not seem to find your pressure infusion cuff to squeeze the IV bag and accelerate fluid administration.

241
241
article thumbnail

With the neuro tide rising, could a breakthrough for Parkinson’s be next?

PharmaVoice

Amid a wave of neuro R&D, scientists are taking an Alzheimer’s-like approach to developing the first disease-modifying treatments for Parkinson’s.

246
246
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

AstraZeneca buys Pfizer’s early gene therapy work for up to $1B

BioPharma Dive

The British pharma is deepening its investment in genetic medicine through a deal for a group of Pfizer’s gene therapy delivery tools, while the New York giant cuts back.

98
article thumbnail

Cases of alpha-gal syndrome caused by tick bites on the rise, CDC reports

STAT

For many Americans, the warmer spring and summer months bring backyard barbecues and scenic hikes — along with a chorus of cicadas, mosquitoes galore, and hypervigilant self-checks for ticks. Often, insect bites only cause mild discomfort but new reports from the Centers for Disease Control and Prevention warn that a food allergy caused by ticks is on the rise in the U.S.

Immunity 246

More Trending

article thumbnail

Big Pharma CEOs get candid about pricing and M&A

PharmaVoice

Head honchos at the biggest pharma companies reporting second-quarter earnings dig into the topics du jour.

241
241
article thumbnail

GSK confident in RSV vaccine launch, but sets expectations for ‘steady build’

BioPharma Dive

GSK expects its respiratory syncytial virus vaccine will be a multibillion dollar product. But at the beginning it’s predicting a slower launch than for its fast-selling shingles shot.

article thumbnail

Mitch McConnell’s abrupt episode has an important public health takeaway

STAT

The handling of Senate Minority Leader Mitch McConnell’s abrupt medical issue this week is raising concerns among medical experts that the event sent a potentially dangerous public-health message — that when someone experiences an episode with symptoms like McConnell’s, they can simply return to work as though nothing had happened.

246
246
article thumbnail

How to Find the Best Digital Marketing Agency for Your Business 

Pharma Marketing Network

In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Increased support and vape use could see three million fewer smokers in UK

The Pharmacist

Ramped up support to help smokers quit, including the prescribing of vapes, could see the UK’s smoking rate halve within the next five to 10 years, a new report has suggested. Meanwhile, the implementation of a sugar and salt reformulation tax, as well as efforts to make healthy foods more affordable and a mandatory calorie […] The post Increased support and vape use could see three million fewer smokers in UK appeared first on The Pharmacist.

98
article thumbnail

Gilead drug acquired in $5B buyout fails key blood cancer trial

BioPharma Dive

Treatment with magrolimab proved ineffective in a Phase 3 study in myelodysplastic syndrome, adding to doubts about so-called CD47 inhibitors as well as Gilead’s deal strategy.

98
article thumbnail

To detect breast cancer sooner, an MIT professor designs an ultrasound bra

STAT

Canan Dagdeviren has dedicated her career to creating tools that can capture data from every nook and cranny of the human body. An electrode that reads brain signals in Parkinson’s patients. A tattoo-like patch to detect skin cancer. And now, a bra containing a flexible ultrasound that could one day be used to more comfortably screen for breast cancer.

246
246
article thumbnail

5 Strategies to Strengthen Relationships with HCPs

Pharma Marketing Network

Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceutical companies, and medical device manufacturers alike. These partnerships not only improve patient outcomes but also foster mutual trust and collaboration. In this blog, we will explore five effective strategies to enhance your relationship-building efforts with HCPs and ultimately achieve better healthcare outcomes.

article thumbnail

You’ve Failed Your Pharmacist Board Certification Exam…Now What?

Med Ed 101

I have received emails from pharmacists regarding board certification and inevitably, I get quite a few people looking for guidance on where to go next after they recently found out they failed their pharmacist board certification exam. We all face failures in life and it is natural to be sad. Make sure you really try […] The post You’ve Failed Your Pharmacist Board Certification Exam…Now What?

98
article thumbnail

Lilly adds to case for Mounjaro’s weight-loss benefits with new study data

BioPharma Dive

The results showed that enrollees who’d already lost weight after diet and exercise shed pounds after receiving Mounjaro, while those who stopped treatment gained weight back.

98
article thumbnail

Asian American doctors, overrepresented in medicine, are largely left out of leadership

STAT

For 15 years, orthopedic surgeon Charles S. Day has been working to highlight the striking lack of diversity in his field, publishing studies showing orthopedics had the fewest Black, Hispanic, and female residents of any surgical specialty. Day himself is Asian American, a group that’s abundant in medicine. But as he dug further, his datasets and personal experiences began to collide.

article thumbnail

How to Customize Your Audience in Ads Manager for the Pharma Industry 

Pharma Marketing Network

Ads Manager is a powerful platform that can help pharma companies reach their target audience and achieve their marketing goals. One of the ways to do this is to customize your audience. This means targeting your ads to people who are most likely to be interested in your products or services. Here are some tips for customizing your audience in Ads Manager for the pharma industry: Use demographics: You can target your ads based on demographics, such as age, gender, location, and interests.

article thumbnail

DrugPatentWatch reveals NIH funding for patents

Drug Patent Watch

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public Interest Protections of… The post DrugPatentWatch reveals NIH funding for patents appeared first on DrugPatentWatch - Make Better Decisions.

97
article thumbnail

Merck, chasing Pfizer, claims study success for new pneumonia vaccine

BioPharma Dive

The pharma said its latest shot, which covers 21 strains of bacteria, cleared two Phase 3 trials and in some cases spurred a stronger immune response than Pfizer’s Prevnar 20.

article thumbnail

Opinion: Enough with the health care policy patchwork. It’s time for universal insurance

STAT

Everyone knows that the United States is the only high-income country without universal health insurance. According to the standard narrative, this is the inevitable result of U.S. exceptionalism — our different values, culture, and institutions. Not so. The impetus for universal coverage is as strong in the United States as in any other country.

246
246
article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. One of the FDA’s enforcement mechanisms is the issuance of marketing violation letters to pharmaceutical companies found in violation of advertising and promotion regulations.

article thumbnail

Filing Strategies for Maximizing Pharma Patents

Drug Patent Watch

In a recent article published by IAM Magazine, titled “Why Pharma Companies Should File Patents Later In The R&D Process,” Alexander R. Trimble, PhD, a prominent patent attorney, explores the… The post Filing Strategies for Maximizing Pharma Patents appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

Roche buys into Alnylam heart drug in cardiovascular research bet

BioPharma Dive

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

article thumbnail

Q&A with CDC Director Mandy Cohen: On communication, trust, and getting things done

STAT

The new director of the Centers for Disease Control and Prevention, Mandy Cohen, is only two weeks into her new job. But already she hears the clock ticking. If all goes well, Cohen — the successor to Rochelle Walensky, who stepped down at the end of June — will have about 18 months at the helm of the world’s premier public health agency before the next U.S. president is sworn in.

article thumbnail

Novel antibody therapeutic demonstrates potential in GVHD

European Pharmaceutical Review

Axatilimab, an anti-CSF-1R antibody to treat chronic graft-versus-host disease (GVHD) has, in a pivotal Phase II trial, demonstrated overall response rates (ORR) of 74 percent, 67 percent and 50 percent, within the first six months of treatment. “[It] is the first investigational chronic GVHD treatment to target inflammation and fibrosis through the inhibition of disease associated macrophages,” stated Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals.

97
article thumbnail

Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

Drug Patent Watch

A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020. The study… The post Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations appeared first on DrugPatentWatch - Make Better Decisions.

97
article thumbnail

How to Increase SEO on Google Ads for the Pharma Industry

Pharma Marketing Network

Google Ads is a great way to reach a wider audience for your pharma business. However, if you want to get the most out of your Google Ads campaigns, you need to optimize them for SEO. Here are some tips on how to increase SEO on Google Ads for the pharma industry: Use relevant keywords: When you’re creating your Google Ads campaigns, make sure to use relevant keywords.

97
article thumbnail

Inside the hospital gardens that give respite from a world of ills

STAT

WILLOWBROOK, Calif. — In this neighborhood just north of Compton, Martin Luther King Jr. Community Hospital catches the light. Tall, sleek, all windows and silver finish, the hospital sits as a kind of promise to South Los Angeles. Not long ago, there was another hospital on the same property. Similar name, too: Martin Luther King Jr./Drew Medical Center.

Hospitals 243
article thumbnail

AstraZeneca links up with Qureight on lung disease research

Pharma Times

The company will utilise Qureight’s AI technology to undergo studies across a variety of complex lung diseases - News - PharmaTimes

103
103
article thumbnail

Biogen to acquire rare disease drugmaker Reata for $7.3B

BioPharma Dive

The deal is a major bet by Biogen and its new CEO Chris Viehbacher, who’s reorganized R&D, cut costs and laid off staff since becoming company head last year.

98
article thumbnail

What’s Next for Biopharma Under the Inflation Reduction Act

PharmExec

As we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.

98
article thumbnail

STAT+: Lawsuit says Cigna illegally denies claims in bulk, sticking patients with unexpected bills

STAT

A new lawsuit accuses Cigna of using an algorithm to automatically deny claims in bulk instead of individually reviewing each case, putting patients on the hook for bills the health insurer otherwise would have paid. The complaint filed Monday in the Northern District of California says Cigna uses a system called PXDX to identify discrepancies between diagnoses and the tests and services it covers for those ailments.

239
239
article thumbnail

How to Go Beyond Demographics for Effective Marketing to Consumers in the Pharma Industry 

Pharma Marketing Network

Traditionally, pharmaceutical companies have relied on demographics to target their marketing efforts. This means that they have focused on reaching consumers based on factors such as age, gender, income, and location. While demographics can be a useful starting point, they are not always enough to create effective marketing campaigns. This is because consumers are not just defined by their demographics.

article thumbnail

Will proposed updates to statutory branded medicines pricing scheme help protect medicine supply?

The Pharmacist

The government has proposed updates to a scheme controlling the cost of branded medicines that it says will help protect medicines supply and keep prices competitive. It has launched a consultation on the statutory scheme to control the cost of branded health service medicines. But the body representing the pharmaceutical industry has criticised the proposals. […] The post Will proposed updates to statutory branded medicines pricing scheme help protect medicine supply?

95